Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 582-585, May 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryan, G. T.
Right arrow Articles by Price, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryan, G. T.
Right arrow Articles by Price, J. M.

Incidence of Mouse Bladder Tumors Following Implantation of Paraffin Pellets Containing Certain Tryptophan Metabolites*

George T. Bryan{dagger}, R. R. Brown{ddagger} and J. M. Price§

( Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin)

Pellets of paraffin wax implanted into the lumen of the bladder of 38 mice induced one carcinoma. An equally low incidence of carcinomas was induced with paraffin wax pellets containing 15–20 per cent suspensions of 8-hydroxyquinoline or quinaldic acid, 8-hydroxyquinaldic acid, xanthurenic acid, the 8-methyl ether of xanthurenic acid, 4,8-quinolinediol, L-kynurenine sulfate, 3-hydroxy-L-kynurenine, and 3-hydroxyanthranilic acid, all metabolites of tryptophan. The inability to produce pellets of uniform composition containing these test substances was demonstrated. Paper chromatographic methods revealed that most of these compounds remained in the paraffin vehicle in vivo for as long as 342 days. It was concluded that paraffin is not a satisfactory vehicle in which to test these urinary tryptophan metabolites for bladder carcinogenicity.

* Supported in part by Grant Nos. E-115A, E-202B, and E-116E from the American Cancer Society; by Grant Nos. A-1127 and A-1499 from the National Institutes of Arthritis and Metabolic Diseases; and by Grant Nos. C-3274 and CF-8245 from the National Cancer Institute, United States Public Health Service; and by the Elsa U. Pardee Foundation.

These results are taken from a thesis submitted by Dr. George T. Bryan to the University of Wisconsin in partial fullfillment of the requirements for the degree of Doctor of Philosophy.

{dagger} Part of this investigation was carried out during the tenure of a Special Fellowship from the National Cancer Institute, United States Public Health Service.

{ddagger} Supported by Research Career Development Award (No. CA-K3-18,404) of the National Cancer Institute, United States Public Health Service.

§ American Cancer Society-Charles S. Hayden Foundation Professor of Surgery in Cancer Research.

Received 8/ 6/63.


This article has been cited by other articles:


Home page
ScienceHome page
G. T. Bryan and E. Erturk
Production of Mouse Urinary Bladder Carcinomas by Sodium Cyclamate
Science, February 13, 1970; 167(3920): 996 - 998.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.